A Study of Axl Inhibitor FC084CSA in Patients With Advanced Malignant Solid Tumors

Exclusion Criteria

• •1. Not recovered from the adverse reactions caused by previous anti-tumor treatments (≥CTCAE grade 1).
• •2. Received anti-tumor therapy within 4 weeks before enrollment.
• •3. Participated in other clinical trials within 4 weeks before enrollment and used clinical investigational drugs during this period.
• •4. Have undergone surgery within 4 weeks before enrollment, and the investigator believes that the patient's state has not recovered to the point where the study can be started.
• •5. Patients with ascites (ascites), pleural effusion (pleural effusion) or pericardial effusion that cannot be controlled by drainage or other methods.
• •6. Central nervous system metastases with clinical symptoms.
• •7. With any situations that the researcher considers inappropriate to participate in this research.